Mevion Medical Systems to price initial public offering of stock

Jefferies and Leerink Partners will be the joint bookrunning managers

By Devika Patel

Knoxville, Tenn., Sept. 11 – Mevion Medical Systems, Inc. will conduct an initial public offering of its common stock with a 30-day greenshoe, according to a Form S-1 filed Thursday with the Securities and Exchange Commission.

Jefferies and Leerink Partners are the joint bookrunning managers. Oppenheimer & Co. is the lead manager and BTIG is the co-manager.

Proceeds will be used to expand manufacturing and global distribution facilities, for research and development, manufacturing, sales and marketing, general and administrative and public company expenses, maintenance capital expenditures and other general corporate purposes, including working capital.

The Littleton, Mass., company provides proton therapy systems for use in radiation treatment for cancer patients. It intends to list its common stock on the Nasdaq under the symbol “MEVI.”

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.